Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$241M Sell
2,293,632
-824,894
-26% -$96.9M 0.79% 26
2025
Q4
$389M Buy
3,118,526
+4,617
+0.1% +$550K 1.19% 10
2025
Q3
$373M Buy
3,113,909
+1,138
+0% +$120K 1.11% 8
2025
Q2
$286M Sell
3,112,771
-31,719
-1% -$2.89M 0.92% 18
2025
Q1
$276M Sell
3,144,490
-462,769
-13% -$45.5M 0.98% 17
2024
Q4
$334M Sell
3,607,259
-120,601
-3% -$11.6M 1.06% 11
2024
Q3
$345M Sell
3,727,860
-110,906
-3% -$9.31M 1.1% 12
2024
Q2
$288M Sell
3,838,766
-139,880
-4% -$11.2M 0.94% 15
2024
Q1
$343M Sell
3,978,646
-82,972
-2% -$6.34M 1.11% 7
2023
Q4
$281M Buy
4,061,618
+1,259,800
+45% +$76M 0.99% 9
2023
Q3
$153M Buy
2,801,818
+2,033,717
+265% +$116M 0.57% 36
2023
Q2
$42.8M Buy
+768,101
New +$38.3M 0.15% 201

Other funds holding CRH

Lord, Abbett & Co's CRH Position: Q1 2026 in Review

Lord, Abbett & Co reduced its CRH (CRH) stake by 26% in Q1 2026, selling an estimated $96.9M and leaving 2,293,632 shares worth $241M. The position accounts for 0.79% of the portfolio, ranked #26.

Lord, Abbett & Co first reported a position in CRH in Q2 2023 and has held it in 12 quarters since. The position peaked at $389M in Q4 2025. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • Lord, Abbett & Co held 2,293,632 shares of CRH worth $241M as of Q1 2026.
  • Lord, Abbett & Co sold 824,894 CRH shares in Q1 2026, an estimated $96.9M.
  • CRH made up 0.79% of Lord, Abbett & Co's portfolio in Q1 2026, its #26 holding.
  • Lord, Abbett & Co first reported a position in CRH in Q2 2023 and has held it in 12 quarters since.
  • Lord, Abbett & Co's CRH position peaked at $389M in Q4 2025.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.